Background Image
Table of Contents Table of Contents
Previous Page  58 / 64 Next Page
Information
Show Menu
Previous Page 58 / 64 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 5, September/October 2020

278

AFRICA

was normal with an EF of 75%, while the diastolic function was

worsened with E (1.0 m/s)/A (0.6 m/s) = 1.7, e

(3.5 m/s)/a

(2.8

m/s) = 1.2 and E/e

= 28.5. A 3.7-mm pericardial effusion was

also identified on the roof of the right atrium.

In addition to diuretics and aldosterone receptor antagonists,

as well as beta-blockers to control the fast heart rate, the patient

received a five-day intravenous dexamethasone infusion at a

dosage of 10 mg once per day, and oral prednisone and warfarin

at the dosage of 75 and 3.5 mg once per day, respectively.

Additionally, cytotoxic hydroxycarbamide, a cytotoxic agent,

was added at a dosage of 500 mg twice per day.

The patient’s symptoms of cough and dyspnoea were

markedly alleviated one week later. His temperature returned

to normal, the rash completely disappeared, and the moist

rales disappeared on both lungs. Repeat chest X-ray revealed

substantially reduced infiltrating shadows with no evidence of

pleural effusion. The WBC count was decreased to 18.54 × 10

9

cells/l, with 37.7% eosinophils and a total blood count of 6.99 ×

10

9

cells/l. The patient was discharged and closely followed up by

his field physicians.

Discussion

IHES is a rare eosinophilic proliferative disease involving

multiple vital organs. It more often occurs in men, and the

ratio of male-to-female is about 9:1.

4

Studies have reported that

cardiac involvement occurs in more than 50% of IHES patients

and is the leading cause of death. The in-hospital death rate due

to cardiac involvement secondary to IHES was reported in one

study to be 12.5%.

7

Eosinophil-mediated cardiac injury occurs in three stages:

5,6

(1) an early necrotic stage characterised by the formation

of myocardial necrosis and micro-abscess due to eosinophil

infiltration and toxic cationic protein released from degranulation

of the eosinophils; (2) an intermediate thrombotic stage

manifesting as the formation of thrombi on the surface of

damaged myocardium; and (3) a late fibrotic phase characterised

by the formation of endomyocardial fibrosis and scar, which is

frequently associated with cardiac diastolic dysfunction and even

restrictive cardiomyopathy. Progressive extensive endomyocardial

fibrosis may also attack the chordae tendineae and papillary

muscles, leading to valvular insufficiency.

10

Fig. 4.

Chest CT. A: image on the first admission showing slightly increased bilateral bronchovascular shadows on the lungs. B:

image on the second admission showing large, flaky, high-density infiltrates throughout the right and inferior left lung.

A

B

Fig. 5.

Frozen images of cine-cardiac magnetic resonance true fast imaging with steady-state free precession sequences. A: four-

chamber view. B: two-chamber view. C: short-axis view. The white asterisks indicate the markedly thickened endocardium

and black arrows indicate the thrombi within the LV cavity.

A

B

C